Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy-Reference-Cited by-同舟云学术

Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy

Published:2020-07 Issue:1 Volume:204 Page:96-103
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Douglawi Antoin¹,Calaway Adam¹,Tachibana Isamu¹,Panizzutti Barboza Marcelo¹,Speir Ryan¹,Masterson Timothy¹,Adra Nabil²,Foster Richard¹,Einhorn Lawrence¹,Cary Clint¹

Affiliation:

1. Department of Urology, Indiana University, Indianapolis, Indiana

2. Department of Hematology/Oncology, Indiana University, Indianapolis, Indiana

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary short‐term peri‐operative outcomes of open primary retroperitoneal lymph node dissection;BJU International;2024-09-03

2. Long-term clinical outcomes of patients with negative pathology (pN0) at primary retroperitoneal lymph node dissection;Clinical Genitourinary Cancer;2024-09

3. Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection;Urologic Oncology: Seminars and Original Investigations;2024-08

4. Primary retroperitoneal lymph node dissection for metastatic non‐seminomatous germ cell tumours: outcomes and adjuvant chemotherapy;BJU International;2024-07-05

5. Iodine‑125 seeds combined with carboplatin in the treatment of retroperitoneal metastatic seminoma: A case report and literature review;Oncology Letters;2024-02-15